Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Sowell, John
Agnew-Heard, Kimberly A
Christian Mason, J
Mama, Charles
Strekowski, Lucjan
and
Patonay, Gabor
2001.
Use of non-covalent labeling in illustrating ligand binding to human serum albumin via affinity capillary electrophoresis with near-infrared laser induced fluorescence detection.
Journal of Chromatography B: Biomedical Sciences and Applications,
Vol. 755,
Issue. 1-2,
p.
91.
Petitpas, Isabelle
Bhattacharya, Ananyo A.
Twine, Sue
East, Malcolm
and
Curry, Stephen
2001.
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin.
Journal of Biological Chemistry,
Vol. 276,
Issue. 25,
p.
22804.
Rich, Rebecca L.
Day, Yasmina S.N.
Morton, Thomas A.
and
Myszka, David G.
2001.
High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE.
Analytical Biochemistry,
Vol. 296,
Issue. 2,
p.
197.
Sowell, John
Mason, J. Christian
Strekowski, Lucjan
and
Patonay, Gabor
2001.
Binding constant determination of drugs toward subdomain IIIA of human serum albumin by near-infrared dye-displacement capillary electrophoresis.
ELECTROPHORESIS,
Vol. 22,
Issue. 12,
p.
2512.
Wallin, Reidar
Hutson, Susan M.
Cain, Dean
Sweatt, Andrew
and
Sane, David C.
2001.
A molecular mechanism for genetic warfarin resistance in the rat.
The FASEB Journal,
Vol. 15,
Issue. 13,
p.
2542.
Baroni, Simona
Mattu, Marco
Vannini, Alessandro
Cipollone, Rita
Aime, Silvio
Ascenzi, Paolo
and
Fasano, Mauro
2001.
Effect of ibuprofen and warfarin on the allosteric properties of haem–human serum albumin.
European Journal of Biochemistry,
Vol. 268,
Issue. 23,
p.
6214.
Il'ichev, Yuri V.
Perry, Jennifer L.
and
Simon, John D.
2002.
Interaction of Ochratoxin A with Human Serum Albumin. A Common Binding Site of Ochratoxin A and Warfarin in Subdomain IIA.
The Journal of Physical Chemistry B,
Vol. 106,
Issue. 2,
p.
460.
Fitos, Ilona
Visy, Júlia
and
Kardos, Julianna
2002.
Stereoselective kinetics of warfarin binding to human serum albumin: Effect of an allosteric interaction.
Chirality,
Vol. 14,
Issue. 5,
p.
442.
Il'ichev, Yuri V
Perry, Jennifer L
Rüker, Florian
Dockal, Michael
and
Simon, John D
2002.
Interaction of ochratoxin A with human serum albumin. Binding sites localized by competitive interactions with the native protein and its recombinant fragments.
Chemico-Biological Interactions,
Vol. 141,
Issue. 3,
p.
275.
Petersen, Charles E.
Ha, Chung‐Eun
Curry, Stephen
and
Bhagavan, Nadhipuram V.
2002.
Probing the structure of the warfarin‐binding site on human serum albumin using site‐directed mutagenesis.
Proteins: Structure, Function, and Bioinformatics,
Vol. 47,
Issue. 2,
p.
116.
Monzani, Enrico
Curto, Maria
Galliano, Monica
Minchiotti, Lorenzo
Aime, Silvio
Baroni, Simona
Fasano, Mauro
Amoresano, Angela
Salzano, Anna Maria
Pucci, Piero
and
Casella, Luigi
2002.
Binding and Relaxometric Properties of Heme Complexes with Cyanogen Bromide Fragments of Human Serum Albumin.
Biophysical Journal,
Vol. 83,
Issue. 4,
p.
2248.
Day, Yasmina S.N.
and
Myszka, David G.
2003.
Characterizing a Drug’s Primary Binding Site on Albumin.
Journal of Pharmaceutical Sciences,
Vol. 92,
Issue. 2,
p.
333.
Perry, Jennifer L.
Il'ichev, Yuri V.
Kempf, Valerie R.
McClendon, Jamal
Park, Gyungse
Manderville, Richard A.
Rüker, Florian
Dockal, Michael
and
Simon, John D.
2003.
Binding of Ochratoxin A Derivatives to Human Serum Albumin.
The Journal of Physical Chemistry B,
Vol. 107,
Issue. 27,
p.
6644.
Liu, Yuan
Xie, Meng-Xia
Kang, Juan
and
Zheng, Dong
2003.
Studies on the interaction of total saponins of panax notoginseng and human serum albumin by Fourier transform infrared spectroscopy.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy,
Vol. 59,
Issue. 12,
p.
2747.
Yamasaki, Keishi
Maruyama, Toru
Takadate, Akira
Suenaga, Ayaka
Kragh‐Hansen, Ulrich
and
Otagiri, Masaki
2004.
Characterization of site I of human serum albumin using spectroscopic analyses: Locational relations between regions Ib and Ic of site I.
Journal of Pharmaceutical Sciences,
Vol. 93,
Issue. 12,
p.
3004.
Gomme, Peter T
and
Bertolini, Joseph
2004.
Therapeutic potential of vitamin D-binding protein.
Trends in Biotechnology,
Vol. 22,
Issue. 7,
p.
340.
Bocedi, Alessio
Notari, Stefania
Menegatti, Enea
Fanali, Gabriella
Fasano, Mauro
and
Ascenzi, Paolo
2005.
Allosteric modulation of anti‐HIV drug and ferric heme binding to human serum albumin.
The FEBS Journal,
Vol. 272,
Issue. 24,
p.
6287.
Yamasaki, Keishi
Kuga, Noriyuki
Takamura, Norito
Furuya, Yumiko
Hidaka, Muneaki
Iwakiri, Tomomi
Nishii, Ryuuichi
Okumura, Manabu
Kodama, Hirofumi
Kawai, Keiichi
and
Arimori, Kazuhiko
2005.
Inhibitory Effects of Amino-Acid Fluids on Drug Binding to Site II of Human Serum Albumin in Vitro.
Biological and Pharmaceutical Bulletin,
Vol. 28,
Issue. 3,
p.
549.
Fasano, Mauro
Curry, Stephen
Terreno, Enzo
Galliano, Monica
Fanali, Gabriella
Narciso, Pasquale
Notari, Stefania
and
Ascenzi, Paolo
2005.
The extraordinary ligand binding properties of human serum albumin.
IUBMB Life (International Union of Biochemistry and Molecular Biology: Life),
Vol. 57,
Issue. 12,
p.
787.
Ahmed, Naila
Dobler, Darin
Dean, Mark
and
Thornalley, Paul J.
2005.
Peptide Mapping Identifies Hotspot Site of Modification in Human Serum Albumin by Methylglyoxal Involved in Ligand Binding and Esterase Activity.
Journal of Biological Chemistry,
Vol. 280,
Issue. 7,
p.
5724.